DEVELOPMENT AND VALIDATION OF A CLINICAL RISK SCORE FOR POSTOPERATIVE OUTCOME IN NEWLY DIAGNOSED GLIOBLASTOMA: A REPORT OF THE RANO RESECT GROUP

被引：0

作者：

Karschnia, P. ^{[1
,2
]}

Young, J. S. ^{[3
,4
]}

Youssef, G. C. ^{[5
,6
]}

Dono, A. ^{[7
]}

Haeni, L. ^{[8
,9
,10
]}

Sciortino, T. ^{[11
]}

Bruno, F. ^{[12
]}

Juenger, S. T. ^{[13
]}

Teske, N. ^{[1
]}

Dietrich, J. ^{[14
]}

Weller, M. ^{[15
,16
]}

Vogelbaum, M. A. ^{[17
]}

van den Bent, M. ^{[18
]}

Beck, J. ^{[8
]}

Thon, N. ^{[1
]}

Gerritsen, J. K. ^{[3
,4
,19
]}

Hervey-Jumper, S. ^{[3
,4
]}

Cahill, D. P. ^{[20
]}

Chang, S. M. ^{[3
,4
]}

Ruda, R. ^{[12
]}

Bello, L. ^{[11
]}

Schnell, O. ^{[8
,21
]}

Esquenazi, Y. ^{[7
]}

Ruge, M. I. ^{[13
]}

Grau, S. J. ^{[13
,22
]}

Huang, R. Y. ^{[6
,23
]}

Wen, P. Y. ^{[5
,6
]}

Berger, M. S. ^{[3
,4
]}

Molinaro, A. M. ^{[3
,4
]}

Tonn, J. ^{[1
,2
]}

机构：

[1] Ludwig Maximilians Univ Munchen, Dept Neurosurg, Munich, Germany

[2] German Canc Consortium DKTK, Partner Site Munich, Munich, Germany

[3] Univ San Francisco, Dept Neurosurg, San Francisco, CA USA

[4] Univ San Francisco, Div Neurooncol, San Francisco, CA USA

[5] Dana Farber Canc Inst, Div Neurooncol, Boston, MA USA

[6] Harvard Med Sch, Boston, MA USA

[7] UT Hlth Houston, McGovern Med Sch, Dept Neurosurg, Houston, TX USA

[8] Univ Freiburg, Med Ctr, Dept Neurosurg, Freiburg, Germany

[9] Bern Univ Hosp, Inselspital, Dept Neurosurg, Bern, Switzerland

[10] Univ Bern, Bern, Switzerland

[11] Univ Milan, Dept Oncol & Hematooncol, Div Neurooncol, Milan, Italy

[12] Univ Turin, Dept Neurosci, Div Neurooncol, Turin, Italy

[13] Univ Cologne, Dept Neurosurg, Cologne, Germany

[14] Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Div Neurooncol,Dept Neurol, Boston, MA USA

[15] Univ Hosp Zurich, Dept Neurol, Zurich, Switzerland

[16] Univ Zurich, Zurich, Switzerland

[17] H Lee Moffitt Canc Ctr & Res Inst, Dept NeuroOncol, Tampa, FL USA

[18] Erasmus MC, Canc Inst, Dept Neurol, Rotterdam, Netherlands

[19] Erasmus MC, Canc Inst, Dept Neurosurg, Rotterdam, Netherlands

[20] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA USA

[21] Friedrich Alexander Univ Erlangen Nuernberg, Dept Neurosurg, Erlangen, Germany

[22] Marburg Univ, Acad Hosp, Klinikum Fulda, Fulda, Germany

[23] Brigham & Womens Hosp, Div Neuroradiol, Boston, MA USA

来源：

NEURO-ONCOLOGY | 2024年 / 26卷

关键词：

D O I：

10.1093/neuonc/noae144.370

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P18.54.B

引用

页码：V111 / V111

页数：1

共 50 条

[21] External Validation of the Impede VTE Risk Score in Newly Diagnosed Multiple Myeloma (MM) Patients
Covut, Fahrettin
Ahmed, Ramsha
Samaras, Christy J.
Anwer, Faiz
Garcia, Alex V. Mejia
Angelini, Dana E.
Faiman, Beth M.
Reed, Janice
Karam, Mary Ann
Schlueter, Kristen
Mathur, Saveta
Hamilton, Kimberly
Rosko, Nathaniel
Valent, Jason
Khouri, Jack
BLOOD, 2019, 134
[22] Development and validation of a risk score to predict the probability of postoperative vomiting in pediatric patients: the VPOP score
Bourdaud, Nathalie
Devys, Jean-Michel
Bientz, Jocelyne
Lejus, Corinne
Hebrard, Anne
Tirel, Olivier
Lecoutre, Damien
Sabourdin, Nada
Nivoche, Yves
Baujard, Catherine
Orliaguet, Gilles A.
PEDIATRIC ANESTHESIA, 2014, 24 (09) : 945 - 952
[23] Development of a Clinical Risk Stratification for Patients with Newly Diagnosed Multiple Myeloma
Mao, Xuehan
Xu, Yan
Yan, Yuting
Liu, Jiahui
Fan, Huishou
Sui, Weiwei
Deng, Shuhui
Li, Zengjun
Qiu, Lugui
An, Gang
BLOOD, 2019, 134
[24] The prognostic value of nestin expression in newly diagnosed glioblastoma: Report from the Radiation Therapy Oncology Group
Chinnaiyan, Prakash
Wang, Meihua
Rojiani, Amyn M.
Tofilon, Philip J.
Chakravarti, Arnab
Ang, K. Kian
Zhang, Hua-Zhong
Hammond, Elizabeth
Curran, Walter, Jr.
Mehta, Minesh P.
RADIATION ONCOLOGY, 2008, 3 (1)
[25] The prognostic value of nestin expression in newly diagnosed glioblastoma: Report from the Radiation Therapy Oncology Group
Prakash Chinnaiyan
Meihua Wang
Amyn M Rojiani
Philip J Tofilon
Arnab Chakravarti
K Kian Ang
Hua-Zhong Zhang
Elizabeth Hammond
Walter Curran
Minesh P Mehta
Radiation Oncology, 3
[26] DEVELOPMENT AND CLINICAL VALIDATION OF A GENETIC RISK SCORE FOR COELIAC DISEASE
Sharp, Seth
Jones, Samuel
Kimmitt, Robert
Weedon, Michael
Halpin, Anne
Wood, Andrew
King, Seema
Beaumont, Robin
Hagopian, William
Turner, Justine
Oram, Richard
GUT, 2019, 68 : A162 - A162
[27] Development and Validation of an Obstetric Comorbidity Risk Score for Clinical Use
Ruppel, Halley
Liu, Vincent X.
Kipnis, Patricia
Hedderson, Monique M.
Greenberg, Mara
Forquer, Heather
Lawson, Brian
Escobar, Gabriel J.
WOMENS HEALTH REPORTS, 2021, 2 (01): : 507 - 515
[28] The development and validation of a risk score to predict the probability of postoperative vomiting in pediatric patients
Eberhart, LHJ
Geldner, G
Kranke, P
Morin, AM
Schäuffelen, A
Treiber, H
Wulf, H
ANESTHESIA AND ANALGESIA, 2004, 99 (06): : 1630 - 1637
[29] Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score
Joanna Rupa-Matysek
Lidia Gil
Maciej Kaźmierczak
Marta Barańska
Mieczysław Komarnicki
Medical Oncology, 2018, 35
[30] Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score
Rupa-Matysek, Joanna
Gil, Lidia
Kazmierczak, Maciej
Baranska, Marta
Komarnicki, Mieczyslaw
MEDICAL ONCOLOGY, 2018, 35 (01)

← 1 2 3 4 5 →